With a grant from PharmaNL, iPsomics further strengthens the Dutch drug development innovation.
With a grant from PharmaNL, iPsomics further strengthens the Dutch drug development innovation.
With a grant from PharmaNL, iPsomics further strengthens the Dutch drug development innovation.
iPsomics will attend the BIO-EUROPE conference in Vienna, Austria. Floris Foijer, CSO and Peter Ketelaar, CEO will participate in the Partnering Event. We look forward to meeting you there.
iPsomics will attend the Swiss Biotech Days in Basel in Basel, Switzerland. Our CEO Peter Ketelaar will participate in the Organ-on-a-Chip Roundtable: Implementation through collaboration between the Netherlands and Switzerland (May 6 – 12:00-12:45)
iPsomics organized its first Scientific Symposium to celebrate 6 months of iPsomics. Three leading experts, Prof. Christine Mummery (LUMC), Prof. Joost Gribnau (ErasmusMC) and Prof. Edwin Cuppen (UMC Utrecht & Hartwig Medical Foundation) discussed the latest developments in organ on a chip,….
iPsomics will attend the EMBO Chromoploidy Conference in Stresa, Italy. Our CSO Floris Foijer is co-organizer and will host the conference’s keynote speaker Prof. Rene Medema (scientific director Princess Maxima Centre for paediatric cancer research, Utrecht).
iPsomics’ CEO Peter Ketelaar and CSO Floris Foijer attended the Innovation for Health event in Rotterdam. Peter Ketelaar presented how PharmaNL made it possible to commercialize two academic facilities into a commercial business (iPsomics) thanks to the PharmaNL program.